1. Hypoxia regulates the expression of tissue factor pathway signaling elements in a rat glioma model
   ROBSON Q. MONTEIRO et al, 2016, Oncology Letters CrossRef
2. Dynamic MR imaging for functional vascularization depends on tissue factor signaling in glioblastoma
   Xiao Chen et al, 2018, Cancer Biology & Therapy CrossRef
3. 99mTc-ixolaris targets glioblastoma-associated tissue factor: In vitro and pre-clinical applications
   Thiago Barboza et al, 2015, Thrombosis Research CrossRef
4. Crosstalk between BCR-ABL and protease-activated receptor 1 (PAR1) suggests a novel target in chronic myeloid leukemia
   Camilla de S. Borges et al, 2018, Experimental Hematology CrossRef
5. Expression of flTF and asTF splice variants in various cell strains and tissues
   Lili Pan et al, 2019, Molecular Medicine Reports CrossRef
6. Expression and clinical significance of CXC chemokines in the glioblastoma microenvironment
   Chenglin Li et al, 2020, Life Sciences CrossRef
7. TF/PAR2 Signaling Axis Supports the Protumor Effect of Neutrophil Extracellular Traps (NETs) on Human Breast Cancer Cells
   Karina Martins-Cardoso et al, 2023, Cancers CrossRef
8. PTEN Plays an Important Role in Thrombin-Mediated Lung Cancer Cell Functions
   Zhishan Xu et al, 2015, BioMed Research International CrossRef
9. Effect of 10 different polymorphisms on preoperative volumetric characteristics of glioblastoma multiforme
   Christian Henker et al, 2016, Journal of Neuro-Oncology CrossRef
10. Rivaroxaban compared to no treatment in ER-negative stage I–III early breast cancer patients (the TIP Trial): study protocol for a phase II preoperative window-of-opportunity study design randomised controlled trial
    John Castle et al, 2020, Trials CrossRef
11. Teprenone ameliorates diclofenac-induced small intestinal injury via inhibiting protease activated receptors 1 and 2 activity
    Guanqun Chao et al, 2021, Biomarkers CrossRef
12. Protease-activated receptors and their biological role—focused on skin inflammation
    Florian Guenther et al, 2015, Journal of Pharmacy and Pharmacology CrossRef
13. Inhibition of proteinase-activated receptor 2 (PAR2) decreased the malignant progression of lung cancer cells and increased the sensitivity to chemotherapy
    Hongjie Huo et al, 2024, Cancer Chemotherapy and Pharmacology CrossRef
14. Protease-activated receptors (PARs)—biology and role in cancer invasion and metastasis
    Marek Z. Wojtukiewicz et al, 2015, Cancer and Metastasis Reviews CrossRef
15. The neuro-glial coagulonome: the thrombin receptor and coagulation pathways as major players in neurological diseases
    Efrat Shavit-Stein et al, 2019, Neural Regeneration Research CrossRef
16. Emerging Role of Neuron-Glia in Neurological Disorders: At a Glance
    Md. Mominur Rahman et al, 2022, Oxidative Medicine and Cellular Longevity CrossRef
17. PAR1 inhibition suppresses the self-renewal and growth of A2B5-defined glioma progenitor cells and their derived gliomas in vivo
    R Auvergne et al, 2016, Oncogene CrossRef
18. ADAM9 expression promotes an aggressive lung adenocarcinoma phenotype
    Céline Mongaret Kossmann et al, 2017, Tumor Biology CrossRef
19. Potential Coagulation Factor-Driven Pro-Inflammatory Responses in Ovarian Cancer Tissues Associated with Insufficient O2 and Plasma Supply
    Shiro Koizume et al, 2017, International Journal of Molecular Sciences CrossRef
20. The intertwined fates of inflammation and coagulation in glioma
    Angela Cho et al, 2018, Mammalian Genome CrossRef
21. CD142 promotes trophoblast cell migration by inhibiting BCL2-related autophagic degradation of IL-8
    Linmei Zheng et al, 2023, In Vitro Cellular & Developmental Biology - Animal CrossRef